ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000217.1|Daunorubicin_1 # 3 # 236 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0000217.1|Daunorubicin_1 	3	236	+	Loose	1900	23.483	mexN	30.91	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATTCGCGTGATCGGGGTCGCCCCGGGAGTGATCGAGACGGGCGCGGGAGTCCGGGCCGGGATGTCCCAGGAGGCGTACGACGGGTTCCTGGAAGCCATGGGACAACGCGTCCCGCTCGGCCGGGTGGGCCGGCCCGAGGACGTCGCGTGGTGGGTGGTGCGGCTCGCCGATCCCGAAGCCGCGTACGCCAGCGGTGCCGTGCTCGCCGTGGACGGGGGGCTGTCGGTGACCTGA	IRVIGVAPGVIETGAGVRAGMSQEAYDGFLEAMGQRVPLGRVGRPEDVAWWVVRLADPEAAYASGAVLAVDGGLSVT	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	7.43	gnl|BL_ORD_ID|2021|hsp_num:0	2217			507	672	chloramphenicol; thiamphenicol
BGC0000217.1|Daunorubicin_2 # 373 # 1320 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.701	BGC0000217.1|Daunorubicin_2 	373	1320	-	Loose	600	26.5646	OprZ	37.5	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCGAGTCGCCGCTTCAGCAGACCGAGCACGAGATCCATACCTCGGCCGCGCCGGACGCCGTGTTCGCCGTGCTGGCCGACGTGCGGTCCTGGCCCGCCGTGTTCCCGCCCAGTGTCCACGTCGAACAGTTGGAGTGCGCGGACTCCAGCGAACGCATCCGCATCTGGGCCACTGCCAACGGCTCGCTTCGTACCTGGACGTCGCGGCGCGAGCTCGACGAGCGGGTCCGGCGCATCCGTTTCCGGCAGGAGACGTCCGCCCACCCCGTCGCAGCCATGGGCGGCGAATGGATCGTCGAGGAAGCCGGTGACGGCGGCACCCGCGTGCGGCTGACGCACGACTTCCGGGCCGTGGACGACGACCCGGAGACGATCGGCTGGATCCATCGGGCCGTGGACCGCAACAGCGAAGCCGAACTGGCGTCGCTGCGCACCGCGCTGGAAGGACCCGACGGCACCGCTCCGACGACCTTCGAGGACACCGTCGTCGTCCGTGGCAGTGCCGAGGACATCTACCGCTTCCTCCATCGCAGCGACCTCTGGGAGAAGCGGCTCTCCCACGTCGCGCGGATCGCGGTCAAGGAGGAGGAACCGGGTCTGCAGCACATGGAGATGGACACCCTCACCGCGGACGGCTCGGTACACACCACCGCGTCGGTGCGCGTGTGCTTCCCCGAACGCCGCCTCATCGTCTACAAGCAACTGCGCACGCCGCCGCTGCTGGCGCTCCATCTCGGCCGCTGGTCGGTCCGTCCCGCCGGCGACGGGGACGGGATCGCCGTCACGTCGGCCCACACCGTGTCCGTGGCCCGCTCGGCGATCCCCGGCATCCTAGGTGCGGGGGCGAATGAGACGGACGCCGTGGACTTCGTCCGCCGGGCCCTGGGCCGCAACAGTCTGCTGACCCTGGAAGCGGCCAGACGGTACGCCGAGTCCAGCGCCTGA	MSESPLQQTEHEIHTSAAPDAVFAVLADVRSWPAVFPPSVHVEQLECADSSERIRIWATANGSLRTWTSRRELDERVRRIRFRQETSAHPVAAMGGEWIVEEAGDGGTRVRLTHDFRAVDDDPETIGWIHRAVDRNSEAELASLRTALEGPDGTAPTTFEDTVVVRGSAEDIYRFLHRSDLWEKRLSHVARIAVKEEEPGLQHMEMDTLTADGSVHTTASVRVCFPERRLIVYKQLRTPPLLALHLGRWSVRPAGDGDGIAVTSAHTVSVARSAIPGILGAGANETDAVDFVRRALGRNSLLTLEAARRYAESSA	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	68.03	gnl|BL_ORD_ID|2408|hsp_num:0	2796			135	231	erythromycin; cefepime
BGC0000217.1|Daunorubicin_3 # 1350 # 2138 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.682	BGC0000217.1|Daunorubicin_3 	1350	2138	-	Loose	500	26.9498	apmA	28.81	3003918	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	ATGTCCGACGCAGCCGACCGGGTCGCACTTGTCACCGGGGGAACCAGCGGCATCGGTCTCGCGGTAGGACGACGCAAGCTCGCCCTGGACGGGACCCGGGTGTTCCTGTGCGCTCGTGACGAGAGCGCCGTCACCGGCACCGTGAAGGAACTTCAGGCATCGGGACTGGAGGTGGAGGGCACGTCCTGCGACGTGCGGAGCACCGACGCTGTCGACCGGCTGGTCCGAACGGCCCGGAACCCGCTTCGGGCGATCGACATCGTCGTCAACAACGCCGGCCGCGGTGGTGGAGGAGTGACCGCCCAGATCACGGACGACCTGTGGTCCGATGTCGTCGACACCAACCTCGGCGGGGCCTTCCGGGTCACCCGCGCCGTCCTCACCGGCGGCGGCATGCAGGAGCACGGCTGGGGCCGGATCATCAACATCGCCTCTACCGGCGGCAAGCAGGGAGTGGCCCTCGGCGCTCCCTACTCCGCCTCCAAGAGCGGCCTGATCGGCTTCACGAAGGCTGTCGCACTGGAGCTGGCCAGGACGGGCATCACGGTCAACGCCGTCTGCCCGGGGTACGTCGAGACGCCCATGGCCCAAGGCGTGCGGCAGCGATACGCCGCCTTCTGGGGGATCACCGAGGACGACGTCCTGGAGAAGTTCCGGGCGAAGATCCCGCTCGGACGCTACTCGACGTCCGACGAGGTGGCCGGAATGGTGCACTACCTGGTCTCCGACAGCGCCGACTCGATCACGGCCCAGGCCATCAATGTCTGTGGTGGCCTCGGCAGTTACTGA	MSDAADRVALVTGGTSGIGLAVGRRKLALDGTRVFLCARDESAVTGTVKELQASGLEVEGTSCDVRSTDAVDRLVRTARNPLRAIDIVVNNAGRGGGGVTAQITDDLWSDVVDTNLGGAFRVTRAVLTGGGMQEHGWGRIINIASTGGKQGVALGAPYSASKSGLIGFTKAVALELARTGITVNAVCPGYVETPMAQGVRQRYAAFWGITEDDVLEKFRAKIPLGRYSTSDEVAGMVHYLVSDSADSITAQAINVCGGLGSY	MKTRLEQVLERYLNGREVAVWGVPTRRLLRALKPFKFHTADRVDPQYHYVVAVTDDDLTDFLSDEQSKSFQYANDYLTFDDEGGELPFERMCFNVPVGRQTYFGDGVVGACENGYIKSIGQFTSINGTAEIHANHQLNMTFVSDDIQNFFNEESMAVFQEKLRKDPKHPYAYSKEPMTIGSDVYIGAHAFINASTVTSIGDGAIIGSGAVVLENVPPFAVVVGVPARIKRYRFSKEMIETLLRVKWWDWSIEEINENVDALISPELFMKKYGSL	95.62	gnl|BL_ORD_ID|2163|hsp_num:0	2395			12	177	apramycin
BGC0000217.1|Daunorubicin_4 # 2317 # 2712 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.715	BGC0000217.1|Daunorubicin_4 	2317	2712	+	Loose	500	26.1794	OXA-55	34.48	3001813	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGAGCAGCGATGCCTCTGGCCAGAACCGAACGACGCCGGCTCCGGGTCGGTGACCTTCGTCAACCGATTCACCCTGAGCGGATCAGCCGAGGACTTCGAGGCGGCGTTCGCCGAAACGGCCGAGTTCCTGTGTCGCCGACCCGGCTTCCGCTGGCACGTCCTGCTGGCGCCGACCGGCTCCGGCTCGGCCGACGTCCGCCCGCAGTACGTGAACATCGCGGTCTGGGACGACGAGGCCTCCTTCCGTGCCGCTGTGGCGCACCCGCAGTTCCCGGCCCACGCGGCCGTCCTGCGGGCGCTGAGCACCAGCGAACCGACCCTGTACCGGTCCCGTCAGATCCGTGTCGCGCCGGGCGCCCCGGCCATGAGCAGGCCCGAAGGGCGGACGACGTGA	MEQRCLWPEPNDAGSGSVTFVNRFTLSGSAEDFEAAFAETAEFLCRRPGFRWHVLLAPTGSGSADVRPQYVNIAVWDDEASFRAAVAHPQFPAHAAVLRALSTSEPTLYRSRQIRVAPGAPAMSRPEGRTT	MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAEQTKVSDVCSEVTAEGWQEVRRWDKLFESAGVKGSLLLWDQKRSLGLSNNLSRAAEGFIPASTFKLPSSLIALETGAVRDETSRFSWDGKVREIAVWNRDQSFRTAMKYSVVPVYQQLAREIGPKVMAAMVRQLEYGNQDIGGQADSFWLDGQLRITAFQQVDFLRQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVRRTPAIGWWVGWLELDDNTVYFAVNLDLASASQLPLRQQLVKQVLKQEQLLP	45.33	gnl|BL_ORD_ID|1154|hsp_num:0	1258			375	462	cloxacillin; oxacillin; cefalotin
BGC0000217.1|Daunorubicin_5 # 2709 # 3965 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.697	BGC0000217.1|Daunorubicin_5 	2709	3965	+	Loose	750	202.216	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	33.92	3003463	protein variant model	R121K, F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAACCGACGGGTCGTCATCACCGGGATGGGTGTGGTGGCCCCGGGAGCCATCGGCATCAAGTCGTTCTGGGAGCTGCTGCTGTCCGGGACCACCGCCACCCGGGCCATCACCACGTTCGACGCCACGCCCTTCCGTTCCCGGATCGCCGCCGAGTGCGACTTCGATCCGGTCGCGGCAGGGCTGTCCGCGGAGCAGGCCCGGCGCCTCGACCGGGCCGGGCAGTTCGCGCTGGTCGCCGGTCAGGAGGCGCTCACTGACAGCGGGCTGCGCATCGGGGAGGACTCCGCCCACCGGGTCGGGGTGTGCGTGGGTACCGCTGTCGGCTGCACGCAGAAACTGGAGTCCGAGTACGTGGCTCTCAGCGCGGGCGGTGCGAACTGGGTCGTGGACCCCCACCGGGGGGCGCCCGAGCTGTACGACTACTTCGTGCCGAGTTCCCTCGCCGCCGAAGTGGCTTGGCTCGCCGGGGCGGAAGGGCCCGTGAACATCGTCTCGGCCGGGTGCACCTCGGGGATCGACTCCATCGGGTACGCCTGCGAACTCATCCGCGAGGGGACGGTGGACGTCATGCTCGCGGGAGGCGTGGACGCCCCCATCGCACCGATCACTGTGGCCTGCTTCGACGCCATCAGGGTGACCTCCGACCACAACGACACACCCGAGACGCTCGCGCCCTTCAGCCGCAGCCGCAACGGCTTCGTGCTGGGCGAGGGTGGTGCGATCGTGGTTCTGGAAGAGGCAGAGGCGGCCGTGCGCAGGGGCGCACGAATCTACGCCGAGATCGGCGGGTACGCCTCACGCGGCAACGCATACCACATGACGGGGCTGCGCGCAGACGGCGCCGAGATGGCTGCGGCGATTACCGCGGCCCTCGACGAAGCCCGCCGCGACCCCTCGGACGTGGACTATGTCAACGCCCACGGAACAGCGACGCGACAGAACGACCGGCACGAAACCTCCGCGTTCAAGCGCTCGCTGGGGGATCACGCGTACCGGGTTCCCATCAGCTCCGTGAAGTCGATGATCGGTCACTCCCTGGGGGCCGCCGGCTCGCTCGAAGTGGCGGCGACCGCACTGGCGGTGGAGTACGGGGCGATCCCGCCGACCGCGAATCTGCACGACCCGGATCCCGAACTCGACCTGGACTACGTGCCGTTGACGGCGCGAGAAAAGCGGGTGCGGCATGCGCTGACGGTGGGCAGCGGCTTCGGCGGCTTCCAGAGCGCCATGCTGTTGAGCCGTCCCGAGAGGTGA	MNRRVVITGMGVVAPGAIGIKSFWELLLSGTTATRAITTFDATPFRSRIAAECDFDPVAAGLSAEQARRLDRAGQFALVAGQEALTDSGLRIGEDSAHRVGVCVGTAVGCTQKLESEYVALSAGGANWVVDPHRGAPELYDYFVPSSLAAEVAWLAGAEGPVNIVSAGCTSGIDSIGYACELIREGTVDVMLAGGVDAPIAPITVACFDAIRVTSDHNDTPETLAPFSRSRNGFVLGEGGAIVVLEEAEAAVRRGARIYAEIGGYASRGNAYHMTGLRADGAEMAAAITAALDEARRDPSDVDYVNAHGTATRQNDRHETSAFKRSLGDHAYRVPISSVKSMIGHSLGAAGSLEVAATALAVEYGAIPPTANLHDPDPELDLDYVPLTAREKRVRHALTVGSGFGGFQSAMLLSRPER	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	100.48	gnl|BL_ORD_ID|1968|hsp_num:0	1943			84	1245	isoniazid
BGC0000217.1|Daunorubicin_7 # 5245 # 6303 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.742	BGC0000217.1|Daunorubicin_7 	5245	6303	+	Loose	300	27.7202	dfrK	30.0	3002869	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGAGCACGCTGCCGGGAGCACCTGGGGACCTCTACGTGGCCGGTTGCGGTGTCTGGCTGCCCCCGCCGGTGACCACGGATCAGGCCCTGGCCGCCGGTCACTGCGACCGCAGGCTCGCCTCCTCGACGCGGATGCTGTCGGTGGCGGTCGCCGACAAGGAGACACCGGCGGAGATGGCGGCCTCGGCGGCCCGGACCGCTGTGGACCGCTCCGGCGTCCCCCCGGCCCGCATCGTCCTCGTCCTGCACGCCAGCCTGTACTTCCAGGGGCACCATCTGTGGGCTCCCGCCTCCTACGTCCAGCGGGTGGCCCTCGGGAACCGTTGCCCCGCCATGGAGGTGCGGCAGGTGTCCAACGGCGGCATGGCCGCCCTGGAGCTCGCCCGCGCGTACCTGCTCGCCGCCCCGGACCGGACGGCCGCTCTCGTCACGACGGGCGACCGGATGAGTCCGCCGGGCTTCGACCGCTGGAACAGACCCCGGCACGTGTACGCCGACGGCGGCACCGCCCTCGTACTGTCCCGGCAGGGAGGCTTCGCCCGGCTGCGTAGCCTGGTGACGGTCTCCGAACCGGTGCTGGAGGGCATGCACCGGGGCGGACACCCGTTCGGCCCGCCGTCCGCGGAGGAGCAGCGGACCGTCGACCTGGACGCGCACAGCGGGCGTACGTGGCCGAGGCGGGAGGCTCGTTCAGCGTCGCCGCGGGTCTCGGCGGGCCAGGAGGAGGCTCTGGCCGGCGCGCTGAAGGCCGCCGGGGTCGGACTCGACGACATCAGCCGGGTCGTGCTGCCGCACATGGGCTGGCGCAGGCTGAGCGCCTCCTACTTCGGAAAGTGGCCGGTTCCGCCCGAGCGGACCACGTGGGAGTTCGGGCGACGGACCGGCCATCTGGGCGGCGGCGACCCGATCGCCGGGTTCGACCACCTCGTGGGCTCCGGCCGCCTCGCCCCGGGGGAATTGTGTCTGCTGGTCAGCGTCGGTGCCGGCTTTAGCTGGTCGTGCGCCGTCGTGGAGTTGCTGGACGCCCGTCGGTGGGCGGCCGCCCCGGCCGCCCGGTGA	MSTLPGAPGDLYVAGCGVWLPPPVTTDQALAAGHCDRRLASSTRMLSVAVADKETPAEMAASAARTAVDRSGVPPARIVLVLHASLYFQGHHLWAPASYVQRVALGNRCPAMEVRQVSNGGMAALELARAYLLAAPDRTAALVTTGDRMSPPGFDRWNRPRHVYADGGTALVLSRQGGFARLRSLVTVSEPVLEGMHRGGHPFGPPSAEEQRTVDLDAHSGRTWPRREARSASPRVSAGQEEALAGALKAAGVGLDDISRVVLPHMGWRRLSASYFGKWPVPPERTTWEFGRRTGHLGGGDPIAGFDHLVGSGRLAPGELCLLVSVGAGFSWSCAVVELLDARRWAAAPAAR	MKVSLIAAMDKNRVLGKENDIPWRIPKDWEYVKNTTKGYPIILGRKNLESIGRALPGRRNIILTRDKGFSFNGCEIVHSIEDVFEICNNEEEIFIFGGEQIYNLFLPYVEKMYITKIHYEFEGDTFFPEVNYEEWSEVSVTQGITDEKNPYTYYFHIYERKAS	215.95	gnl|BL_ORD_ID|1765|hsp_num:0	1913			66	231	trimethoprim
BGC0000217.1|Daunorubicin_8 # 6314 # 7330 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.752	BGC0000217.1|Daunorubicin_8 	6314	7330	+	Loose	2090	27.7202	cmeB	35.71	3000784	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACGTGCCCGCGATTCTCCTGATGTTCCCGGGGCAGGGGTCCCAGCACGCGAGGATGGCAGCCGGGCTGTACGGATCCGAACCGGTCTTCACCGCTGCCATGGACGAGGTCCTCGCCGCGTACGATGCCGCCGGCGACTGTGAGGGCCAGCGGCTGCGTGCCGACTGGCTGAGCGACCGTCCAGCCGTGCCGCTGGACCACGTCACCCGGTCCCAGCCGCTGTTGTTCGCGGTGGACTACGCCCTCGGCAGGATGGTACTGGCCACGACGGGCCGGCCGTGGGCCCTGCTCGGGCACAGTGTCGGCGAGATGGCGGGGGCCGCGCTCGCCGGGGTGTTCACGCTGCGCGACGCGGCCTGCCTCCTGCTGGACCGGGTGCGACGGCTGGCCCAGGCACCGCCCGGGGGGATGCTGGCGGTCGCCGCGGGCGAGGACGTGCTGGGCCCGTATCTCGTGGAGGGGGAGGTGGCGGTCGCGGCCGTCAACTCGCCCCGCCAGACCATCCTCGCCGGCCCCGTCGCACCGCTCGCCGCGGTCGCCCGGGCACTGCGGGAGGCGGGGCTCACATGCCGTGAGGTGCCCTCGCTGACCGCATTCCACAGTCCGGTGCTGGCCCCGTACACGACGGGGGCGGCCGAGCGGTTCGCATCGACGCGCGTGGCGGCGCCGTCCATCCCTCTCCGCTCCGGGTACCGGCCGGGCGCGGTGACCGGGCGACTGGCCGCCGACCCGTCCTACTGGGCCGGACATCCCGTGGAGACGGTCCGCTTCTGGCCGGCACTGGACGCGATGCTCCGCTCCCGCACGGGCGTCGTCTGCCTGGAGACCGGGCCGGGGCAGGGGCTCAGCACCGTCGCCCGCCGCCATCCGACGGTGCGGTCGGGGAGGAACGCGGTGGTGTCGCTGCTGCCGCCGCGGGCCGGCACCGCCGAGATGGACCGGACGTCCGTGGCGGCGGCGCTGACCGCAGTGCGCGAGCGGGGCGCTGTGCTCAGTGGGCGACCCGGGCGGTGA	MDVPAILLMFPGQGSQHARMAAGLYGSEPVFTAAMDEVLAAYDAAGDCEGQRLRADWLSDRPAVPLDHVTRSQPLLFAVDYALGRMVLATTGRPWALLGHSVGEMAGAALAGVFTLRDAACLLLDRVRRLAQAPPGGMLAVAAGEDVLGPYLVEGEVAVAAVNSPRQTILAGPVAPLAAVARALREAGLTCREVPSLTAFHSPVLAPYTTGAAERFASTRVAAPSIPLRSGYRPGAVTGRLAADPSYWAGHPVETVRFWPALDAMLRSRTGVVCLETGPGQGLSTVARRHPTVRSGRNAVVSLLPPRAGTAEMDRTSVAAALTAVRERGAVLSGRPGR	MFSKFFIERPVFASVVAIIISLAGVIGLTNLPIEQYPSLTPPTVKVSATYTGADAQTIASTVASPIEDAINGADNMIYMDSTSSSSGTMSLTVYFDIGTDPDQATIDVNNRISAATAKMPDAVKKLGVTVRKTSSATLAAISMYSSDGSMSAVDVYNYIALNVLDELKRVPGVGDANAIGNRNYSLRIWLKPDLLNKFKITATDVISAVNDQNAQYATGKIGEEPVTQKSPYVYSITMQGRLQNPSEFENIILRTNDDGSFLRLKDIADVEIGSQQYSSQGRLNGNDAVPIIINLQSGANALHTAELVQAKMQELSKNFPKGLTYKIPYDTTKFVIESIKEVIKTFIEALILVIIVMYMFLKNFRATLIPMIAVPVSLLGTFAGLYVLGFSINLLTLFALILAIGIVVDDAIIVVENIDRILHENEQISVKDAAIQAMQEVSSPVISIVLVLCAVFIPVSFISGFVGEIQRQFALTLAISVTISGFVALTLTPSLCALFLRRNEGEPFKFVRKFNDFFDWSTSVFSAGVAYILKRTIRFVLIFCIMLGTIFYLNKAVPNSLVPEEDQGLMIGIINLPSASALHRTISEVDHISQEVLKTNGIKDAMAMIGFDLFTSSLKENAAAMFIGLQDWKDRNVSADKIAMELNKKFAFDRNASSIFIGLPPIPGLSITGGFEMYVQNKSGKSYDQIQKDVNKLVAAANQRKELSRVRTTLDTTFPQYKLIIDRDKLKHYNLNMQDVFNTMNATIGTYYVNDFSMLGKNFQVNIRAKGDFRNTQDALKNIFVRSNDGKMIPLDSFLTLQRSSGPDDVKRFNLFPAAQVQGQPAPGYTSGQAIEAIAQVAKETLGDDYSIAWSGSAYQEVSSKGTASYAFALGMIFVFLILAAQYERWLIPLAVVTAVPFAVFGSFLLVYLRGFSNDIYFQTGLLLLIGLSAKNAILIVEFAMEERFKKGKGVFEAAVAAAKLRFRPIIMTSLAFTFGVLPMIFATGAGSASRHSLGTGLIGGMIAASTLAIFFVPLFFYLLENFNEWLDKKRGKIHE	32.50	gnl|BL_ORD_ID|689|hsp_num:0	748			30	195	erythromycin; cefotaxime; fusidic acid
BGC0000217.1|Daunorubicin_9 # 7308 # 7508 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.706	BGC0000217.1|Daunorubicin_9 	7308	7508	-	Loose	725	24.2534	SRT-3	35.9	3006853	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	SRT beta-lactamase	ATGACGGCCCCGTCCAGCGAGACGTGGGTGGACTGGTCCCACACCCAGGGCATGCGTCTGCTGTGGCAGAACCTCCCGCAGCCGCAGCGAACGGAACTGCGCGCACGGCTCGTCGAGGGACTCGACAAGCTGAGCGACGCCACCGGGGCCCTCGCCATCGACGTGCCTGTCCGCTTCGTCACCGCCCGGGTCGCCCACTGA	MTAPSSETWVDWSHTQGMRLLWQNLPQPQRTELRARLVEGLDKLSDATGALAIDVPVRFVTARVAH	MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASHYLPELRGSAFDGVSLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDRPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQAKVAQPWREALAATHVGYYKAGVFTQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDRVEAAYRIVQALDKR	17.46	gnl|BL_ORD_ID|4594|hsp_num:0	5664			849	957	
BGC0000217.1|Daunorubicin_10 # 7505 # 8089 # -1 # ID=1_10;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.658	BGC0000217.1|Daunorubicin_10 	7505	8089	-	Loose	400	31.187	Erm(34)	23.39	3000600	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GAATTCTTCACGCCCATGGGTCGCCGCCTGGTGGACATCTCGGAGCCGGTCACGGGTGAACGAGTGCTCGACATCGGCTGCGGGCGCGGCGCATGCCTTTTCCCGGCTGCGGAAAAGGTCGGCTCCCAGGGGTGCGTCCACGGTATCGACATCGCTCCCGGAATGATCGAGGAAGCTCGCAAGGAAGCCACCGAACGCGGTCTGCGGAATATCAGCCTCATGGTGATGGATGCGGAGACACCCGGATTTCCGGCGCGTTCCTTCGACCTGGTCATGGGGAGCTACAGCGTCATTTTCCTGCCGGATGCCGTGGGGGCCCTCGCGCGCTACGCCGACATCCTGGACCACGGCGGCAGGATCGCGTTCACCAGCCCGGTCTTCCGTGCCGGCACGTTCCCGTTCCTGCCGCCGGAGTTCACCCCGCTCATCCCCCAGGCATTGCTGGAGCACCTCCCCGAGCAGTGGCGGCCCGAGGCGCTGGTCCGGCGGTTCAACAGCTGGCTGGAGCGAGCCGAGGATCTTGTCCGTACCCTTGAAGGCTGCGGTTACGCTCGTCTCCGTCAGTCGACGAGCCGGTGCGGATGA	EFFTPMGRRLVDISEPVTGERVLDIGCGRGACLFPAAEKVGSQGCVHGIDIAPGMIEEARKEATERGLRNISLMVMDAETPGFPARSFDLVMGSYSVIFLPDAVGALARYADILDHGGRIAFTSPVFRAGTFPFLPPEFTPLIPQALLEHLPEQWRPEALVRRFNSWLERAEDLVRTLEGCGYARLRQSTSRCG	MTKKMNKYNGKKLSRGEPPNFSGQHFMHNKRLLKEIVDKADVSVRDTVLELGAGKGALTTILSERADRVLAVEYDQKCIEALQWKLVGSKNVSILHQDIMKVALPTEPFVVVSNIPYSITTAIMKMLLNNPKNKLQRGAIVMEKGAAKRFTSVSPKDAYVMAWHMWFDIHYERGISRSSFSPPPKVDSALVRIVRKQHPLFPYKEAKAMHDFLSYALNNPRAPLDQVLRGIFTAPQAKKVRQAIGVKPETPVAMLHARQWAMVCDAMVRHVPKVYWPRRKR	69.04	gnl|BL_ORD_ID|7|hsp_num:0	11			99	456	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
